BWA
LEGN icon

Basecamp Wealth Advisors’s Legend Biotech LEGN Stock Holding History

Basecamp Wealth Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44
Closed -$957 – 2111
2025
Q4 		$957 Buy
+44
New +$1.26K ﹤0.01% 1505

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Basecamp Wealth Advisors's LEGN Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 44 shares — an estimated $957 sold.

Basecamp Wealth Advisors first reported a position in LEGN in Q4 2025 and held it in 1 quarter. The position peaked at $957 in Q4 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Basecamp Wealth Advisors reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Basecamp Wealth Advisors sold 44 Legend Biotech shares in Q1 2026, an estimated $957.
  • Basecamp Wealth Advisors first reported a position in Legend Biotech in Q4 2025 and held it in 1 quarter.
  • Basecamp Wealth Advisors's Legend Biotech position peaked at $957 in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.